INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 458m ago
HOUSE PTR57m ago
SEC 13F57m ago
ROBINHOOD CHAIN57m ago
SEC FORM 4/Grant or awardVerified data

Leite John reported VCYT

Chief Commercial Officer-CLIA · VERACYTE, INC. · Common Stock

Side
A
Value
—
Shares
47.1K
Price
—
Executed
Feb 26, 2026
Disclosed
Mar 2, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Feb 26 executedMar 2, 2026 disclosed

VCYT · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
17/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+13 / 25

No reported dollar value · 57.4% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+4 / 15

    2 prior trades recorded in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · VCYT

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    12
    WJ
    Wygant JonathanVP, Chief Accounting Officer
    VCYTVERACYTE, INC.
    Tax withholding
    		F$66K
    1,306 sh
    		Oct 28, 2026Oct 29, 2026
    traded Oct 28, 2026
    		+1dSEC FORM 4

    Evidence

    20
    HJ
    Holstein JensDirector
    VCYTVERACYTE, INC.
    Open-market sale · 10b5-1 plan
    		SELL$375K
    7,500 sh
    		Oct 27, 2026Oct 28, 2026
    traded Oct 27, 2026
    		+1dSEC FORM 4

    Evidence

    9
    HJ
    Holstein JensDirector
    VCYTVERACYTE, INC.
    Option exercise · 10b5-1 plan
    		M$265K
    7,500 sh
    		Oct 27, 2026Oct 28, 2026
    traded Oct 27, 2026
    		+1dSEC FORM 4

    Evidence

    30
    HJ
    Holstein JensDirector
    VCYTVERACYTE, INC.
    Open-market sale · 10b5-1 plan
    		SELL$353K
    7,500 sh
    		Sep 24, 2026Oct 28, 2026
    traded Sep 24, 2026
    		+34dSEC FORM 4

    Evidence

    19
    HJ
    Holstein JensDirector
    VCYTVERACYTE, INC.
    Option exercise · 10b5-1 plan
    		M$265K
    7,500 sh
    		Sep 24, 2026Oct 28, 2026
    traded Sep 24, 2026
    		+34dSEC FORM 4

    Evidence

    7
    HJ
    Holstein JensDirector
    VCYTVERACYTE, INC.
    Option exercise · 10b5-1 plan
    		M—
    7,500 sh
    		Oct 27, 2026Oct 28, 2026
    traded Oct 27, 2026
    		+1dSEC FORM 4

    Evidence

    13
    HJ
    Holstein JensDirector
    VCYTVERACYTE, INC.
    Option exercise · 10b5-1 plan
    		M—
    7,500 sh
    		Sep 24, 2026Oct 28, 2026
    traded Sep 24, 2026
    		+34dSEC FORM 4

    Evidence

    13
    BM
    Bhanji MunaDirector
    VCYTVERACYTE, INC.
    Open-market sale · 10b5-1 plan
    		SELL$81K
    1,864 sh
    		Oct 19, 2026Oct 20, 2026
    traded Oct 19, 2026
    		+1dSEC FORM 4

    Evidence

    9
    LJ
    Leite JohnGlobal Chief Commercial Off
    VCYTVERACYTE, INC.
    Open-market sale · 10b5-1 plan
    		SELL$161K
    4,015 sh
    		Sep 21, 2026Sep 22, 2026
    traded Sep 21, 2026
    		+1dSEC FORM 4

    Evidence

    9
    CR
    Chambers RebeccaChief Financial Officer
    VCYTVERACYTE, INC.
    Open-market sale · 10b5-1 plan
    		SELL$106K
    2,477 sh
    		Sep 4, 2026Sep 4, 2026
    traded Sep 4, 2026
    		+0dSEC FORM 4

    Evidence

    8
    LJ
    Leite JohnGlobal Chief Commercial Off
    VCYTVERACYTE, INC.
    Tax withholding
    		F$178K
    3,961 sh
    		Sep 2, 2026Sep 4, 2026
    traded Sep 2, 2026
    		+2dSEC FORM 4

    Evidence

    0
    CR
    Chambers RebeccaChief Financial Officer
    VCYTVERACYTE, INC.
    Tax withholding · 10b5-1 plan
    		F$162K
    3,603 sh
    		Sep 2, 2026Sep 4, 2026
    traded Sep 2, 2026
    		+2dSEC FORM 4

    Evidence

    9
    CR
    Chambers RebeccaChief Financial Officer
    VCYTVERACYTE, INC.
    Open-market sale · 10b5-1 plan
    		SELL$51K
    1,175 sh
    		Sep 4, 2026Sep 4, 2026
    traded Sep 4, 2026
    		+0dSEC FORM 4

    Evidence

    0
    MA
    McGuire AnnieEVP, General Counsel
    VCYTVERACYTE, INC.
    Tax withholding · 10b5-1 plan
    		F$144K
    3,215 sh
    		Sep 2, 2026Sep 4, 2026
    traded Sep 2, 2026
    		+2dSEC FORM 4

    Evidence

    6
    MA
    McGuire AnnieEVP, General Counsel
    VCYTVERACYTE, INC.
    Open-market sale · 10b5-1 plan
    		SELL$92K
    2,154 sh
    		Sep 4, 2026Sep 4, 2026
    traded Sep 4, 2026
    		+0dSEC FORM 4

    Evidence

    3
    MA
    McGuire AnnieEVP, General Counsel
    VCYTVERACYTE, INC.
    Open-market sale · 10b5-1 plan
    		SELL$48K
    1,100 sh
    		Sep 4, 2026Sep 4, 2026
    traded Sep 4, 2026
    		+0dSEC FORM 4

    Evidence

    20
    ARK Investment Management LLC13F filer
    VCYTVERACYTE, INC.
    TRIM
    		SELL$44.51M
    757.9K sh
    		Not disclosedAug 14, 2026quarterlySEC 13F

    Evidence

    17
    MF
    Miller Thomas F.Director
    VCYTVERACYTE, INC.
    Grant or award
    		A—
    5,272 sh
    		Jun 11, 2026Jun 15, 2026
    traded Jun 11, 2026
    		+4dSEC FORM 4

    Evidence

    13
    BE
    Barr EliavDirector
    VCYTVERACYTE, INC.
    Grant or award
    		A—
    5,272 sh
    		Jun 11, 2026Jun 15, 2026
    traded Jun 11, 2026
    		+4dSEC FORM 4

    Evidence

    11
    MA
    McGuire AnnieEVP, General Counsel
    VCYTVERACYTE, INC.
    Open-market sale · 10b5-1 plan
    		SELL$89K
    1,776 sh
    		Jun 4, 2026Jun 4, 2026
    traded Jun 4, 2026
    		+0dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001991536-26-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Feb 26, 2026
    Published
    Mar 2, 2026
    Ingested by INSIDER
    Nov 5, 04:14 UTC
    Last re-read
    Nov 5, 04:14 UTC

    Extracted facts

    Filer
    Leite John
    Role
    Chief Commercial Officer-CLIA
    Transaction
    Grant or awardAs filed: “A”
    Asset
    VERACYTE, INC.
    Ticker
    VCYT
    Shares
    47.1K
    Price per share
    $0
    Execution date (reported)
    Feb 26, 2026
    Owned after transaction
    129.3K shares
    Days from execution to publication
    4

    What this establishes

    Leite John filed this Form 4 reporting a grant or award of VCYT on Feb 26, 2026. It became public on Mar 2, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Chief Commercial Officer-CLIA
    Leite Johncik:0001991536
    Issuer
    VERACYTE, INC.cik:0001384101

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.